| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Cumberland Pharmaceuticals Inc.
13G
CPIX · 230770109
|
38.4% |
2/9/2026
Event 1/30/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.